Title : Chronic hepatitis of trematode etiology: Innovative technologies of intraduodenal therapy and quantum-hydrogen liver regeneration
Abstract:
Modern international hepatology focuses predominantly on the therapy of viral hepatitis, frequently ignoring concomitant pathologies that provoke, sustain, and exacerbate chronic liver inflammation. Our 30-year clinical experience proves that chronic parasitic infestations are a leading hidden factor in the destruction of the hepatobiliary system. Regions with high consumption of marine fish and seafood are under the primary attack, being totally infected with liver trematodes (Clonorchis and Opisthorchis), officially classified by the WHO as Group 1 carcinogens. Parasites and their waste products completely obstruct the bile ducts with mucus. This causes total cholestasis, disrupts the detoxification function of the liver, and provokes severe endogenous intoxication, turning any inflammation into an incurable chronic form.
For the first time in the world, we have developed and protected by a system of international patents (EA patents No. 047494 and No. 051924) a comprehensive program for the radical eradication of this pathology. In the first stage, specialized phytosolutions that have undergone preliminary contactless hydrogen activation are administered directly into the duodenum via a classical Ryle's tube, completely bypassing the gastric barrier. In the second stage, for the first time in global clinical practice, targeted antiparasitic therapy is executed: specific medicinal drugs are delivered through the same Ryle's tube directly to the locus of infection, ensuring maximum concentration of the active substance right at the parasites while eliminating systemic toxicity. This entire process is sustained by the implementation of restorative hydrogen IV drips and solutions with a deep negative potential. The program concludes with the transanal transplantation of the patient's native autoflora, which has undergone preliminary contactless hydrogen activation. The high bioelectrical charge of the activated strains ensures an immediate systemic immunomodulatory effect, completely blocking the translocation of intestinal endotoxins into the portal vein and minimizing the antigenic load on hepatocytes. This serves as the primary trigger for restoring immune homeostasis and accelerating liver tissue regeneration. The method opens a fundamentally new direction in global hepatology.
